相似文献
1
Chilblain-like lesions after BNT162b2 mRNA COVID-19 vaccine: a case report suggesting that 'COVID toes' are due to the immune reaction to SARS-CoV-2.
J Eur Acad Dermatol Venereol. 2021 Oct;35(10):e630-e632. doi: 10.1111/jdv.17451. Epub 2021 Jun 30.
2
'Blue toes' following vaccination with the BNT162b2 mRNA COVID-19 vaccine.
J Travel Med. 2021 Jun 1;28(4). doi: 10.1093/jtm/taab024.
3
BNT162b2 mRNA COVID-19 vaccine-induced chilblain-like lesions reinforces the hypothesis of their relationship with SARS-CoV-2.
J Eur Acad Dermatol Venereol. 2021 Aug;35(8):e493-e494. doi: 10.1111/jdv.17320. Epub 2021 May 10.
4
Chilblain-like lesions onset during SARS-CoV-2 infection in a COVID-19-vaccinated adolescent: case report and review of literature.
Ital J Pediatr. 2022 Jun 13;48(1):93. doi: 10.1186/s13052-022-01296-5.
5
[COVID-toes, a cutaneous sign of innate resistance to SARS-CoV-2].
Rev Med Suisse. 2021 Mar 31;17(732):646-652.
6
Bilateral Chilblain-like Lesions of the Toes Characterized by Microvascular Remodeling in Adolescents During the COVID-19 Pandemic.
JAMA Netw Open. 2021 Jun 1;4(6):e2111369. doi: 10.1001/jamanetworkopen.2021.11369.
7
Not only toes and fingers: COVID vaccine-induced chilblain-like lesions of the knees.
J Eur Acad Dermatol Venereol. 2022 Jul;36(7):e497-e498. doi: 10.1111/jdv.18025. Epub 2022 Mar 8.
8
Chilblain lesions after COVID-19 mRNA vaccine.
Br J Dermatol. 2021 Jul;185(1):e3. doi: 10.1111/bjd.20060. Epub 2021 Apr 26.
9
Pediatric COVID toes and fingers.
Clin Dermatol. 2021 Jan-Feb;39(1):84-91. doi: 10.1016/j.clindermatol.2020.12.016. Epub 2021 Jan 14.
10
The initial impact of a national BNT162b2 mRNA COVID-19 vaccine rollout.
Int J Infect Dis. 2021 Jul;108:116-118. doi: 10.1016/j.ijid.2021.05.021. Epub 2021 May 13.
引用本文的文献
1
Cases of Pernio-Like Lesions after mRNA-1273 Vaccination with Clinical and Pathological Features: A Single-Center Experience.
Ann Dermatol. 2023 Nov;35(Suppl 2):S281-S286. doi: 10.5021/ad.21.307.
2
COVID-associated non-vasculitic thrombotic retiform purpura of the face and extremities: A case report.
Clin Case Rep. 2022 Dec 27;10(12):e6790. doi: 10.1002/ccr3.6790. eCollection 2022 Dec.
3
SARS-CoV-2 Vaccination and Chilblain-like Lesions: What Do We Know so Far?
Dermatol Pract Concept. 2022 Oct 1;12(4):e2022170. doi: 10.5826/dpc.1204a170. eCollection 2022 Nov.
4
Cutaneous Reactions Following COVID-19 Vaccination: A Review of the Current Literature.
Clin Cosmet Investig Dermatol. 2022 Nov 6;15:2369-2382. doi: 10.2147/CCID.S388245. eCollection 2022.
5
Autoimmune and autoinflammatory conditions after COVID-19 vaccination. New case reports and updated literature review.
J Autoimmun. 2022 Oct;132:102898. doi: 10.1016/j.jaut.2022.102898. Epub 2022 Aug 24.
6
The Impact of COVID-19 Pandemic on Dermatological Conditions: A Novel, Comprehensive Review.
Dermatopathology (Basel). 2022 Jun 29;9(3):212-243. doi: 10.3390/dermatopathology9030027.
7
"COVID toes": A true viral phenomenon or a diagnosis without a leg to stand on?
JAAD Int. 2022 Dec;9:1-6. doi: 10.1016/j.jdin.2022.06.012. Epub 2022 Jun 19.
8
COVID toes following vaccination.
Proc (Bayl Univ Med Cent). 2022 Mar 15;35(4):476-479. doi: 10.1080/08998280.2022.2043732. eCollection 2022.
9
Post-SARS-CoV-2 vaccination COVID toes and fingers : Two case reports and a short literature review.
Wien Med Wochenschr. 2023 Sep;173(11-12):267-269. doi: 10.1007/s10354-022-00944-z. Epub 2022 Jun 23.
10
Chilblain-like lesions onset during SARS-CoV-2 infection in a COVID-19-vaccinated adolescent: case report and review of literature.
Ital J Pediatr. 2022 Jun 13;48(1):93. doi: 10.1186/s13052-022-01296-5.
本文引用的文献
1
Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases.
J Am Acad Dermatol. 2021 Jul;85(1):46-55. doi: 10.1016/j.jaad.2021.03.092. Epub 2021 Apr 7.
2
Delayed Large Local Reactions to mRNA-1273 Vaccine against SARS-CoV-2.
N Engl J Med. 2021 Apr 1;384(13):1273-1277. doi: 10.1056/NEJMc2102131. Epub 2021 Mar 3.
3
'Blue toes' following vaccination with the BNT162b2 mRNA COVID-19 vaccine.
J Travel Med. 2021 Jun 1;28(4). doi: 10.1093/jtm/taab024.
4
Spectrum of Clinicopathologic Findings in COVID-19-induced Skin Lesions: Demonstration of Direct Viral Infection of the Endothelial Cells.
Am J Surg Pathol. 2021 Mar 1;45(3):293-303. doi: 10.1097/PAS.0000000000001634.
5
Clinical, Laboratory, and Interferon-Alpha Response Characteristics of Patients With Chilblain-like Lesions During the COVID-19 Pandemic.
JAMA Dermatol. 2021 Feb 1;157(2):202-206. doi: 10.1001/jamadermatol.2020.4324.
6
Most chilblains observed during the COVID-19 outbreak occur in patients who are negative for COVID-19 on polymerase chain reaction and serology testing.
Br J Dermatol. 2020 Nov;183(5):866-874. doi: 10.1111/bjd.19377. Epub 2020 Aug 9.
7
COVID-19 and outbreak of chilblains: are they related?
J Eur Acad Dermatol Venereol. 2020 Dec;34(12):e757-e758. doi: 10.1111/jdv.16779. Epub 2020 Jul 21.
8
SARS-CoV-2 endothelial infection causes COVID-19 chilblains: histopathological, immunohistochemical and ultrastructural study of seven paediatric cases.
Br J Dermatol. 2020 Oct;183(4):729-737. doi: 10.1111/bjd.19327. Epub 2020 Aug 5.
9
Chilblain-like acral lesions during the COVID-19 pandemic ("COVID toes"): Histologic, immunofluorescence, and immunohistochemical study of 17 cases.
J Am Acad Dermatol. 2020 Sep;83(3):870-875. doi: 10.1016/j.jaad.2020.05.145. Epub 2020 Jun 2.
Zotero 插件